logo-loader

New Tissue Regenix CFO to step into role earlier than anticipated

Published: 18:17 29 Oct 2018 AEDT

ribbon being cut
Jones is joining from Applied Graphene Materials

The new chief financial officer of Tissue Regenix Group PLC (LON:TRX) has joined regenerative medical devices company a month earlier than expected.

Gareth Jones’ appointment was first unveiled back in July and he was originally scheduled to take up his new role at the end of November.

READ: Tissue Regenix appoints new CFO

But he has already completed the handover process in his previous position as the chief number cruncher at Applied Graphene Materials PLC (LON:AGM).

“I am delighted to welcome Gareth to the group,” said chief executive Steve Couldwell.

“He will play a pivotal role in the strategic direction, focus and acceleration of our commercial success.

He added: “Utilising his experience and knowledge of both operational and financial enhancement initiatives, alongside his international and listed company experience, we expect Gareth to help execute on our vision and accelerate sustainable long-term shareholder value.”

Tissue Regenix CEO excited to soon be selling first products in UK

Steve Couldwell, chief executive of Tissue Regenix Group PLC (LON:TRX), caught up with Proactive's Andrew Scott following the appointment of Gareth Hywel Jones as their chief financial officer as well as the big news last month that they've been granted a Human Tissue Authority licence which...

on 13/7/18